Schellhorn, Germany

Stefan Rose-John

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 55(Granted Patents)


Location History:

  • Mainz, DE (1999 - 2006)
  • Kiel, DE (2009)
  • Schelhorn, DE (2011)
  • Schellhorn, DE (2012 - 2017)

Company Filing History:


Years Active: 1999-2017

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Stefan Rose-John

Introduction

Stefan Rose-John, an accomplished inventor based in Schellhorn, DE, has made significant strides in the field of biomedical research, holding a remarkable portfolio of 12 patents. His work primarily focuses on developing innovative treatments for various health conditions, showcasing his ingenuity and commitment to improving human health.

Latest Patents

Among Stefan Rose-John's latest innovations is a patent addressing the treatment of obesity. This invention outlines a method for increasing lipid oxidation in mammals by administering a ligand that interacts with the IL-6 receptor. This method also aims to enhance insulin sensitivity, making it essential for managing and preventing conditions linked to unwanted lipid accumulation, such as obesity, type II diabetes, cardiovascular disease, and more.

Another notable patent involves the development of ciliary neurotrophic factor variants, which includes nucleic acid molecules that can bind to the ciliary neurotrophic factor receptor. This invention explores novel peptides that may have lower affinity interactions with the IL-6 receptor, opening new avenues for therapeutic interventions in various metabolic conditions.

Career Highlights

Stefan Rose-John's career is underscored by his association with prominent institutions such as Conaris Research Institute AG and Christian-Albrechts-University of Kiel. His research and contributions have garnered attention and accolades, reflecting his dedication to advancing science and medicine.

Collaborations

Throughout his career, Stefan has collaborated with notable colleagues, including Dirk Seegert and Nikolaus Rahaus. These partnerships have further enriched his research endeavors and contributed to the successful development of his innovative patents.

Conclusion

Stefan Rose-John's innovative patents and contributions to biomedical research exemplify the critical role inventors play in addressing significant health challenges. His commitment to improving health outcomes through groundbreaking methods demonstrates the power of innovation in transforming lives. As he continues to forge ahead, the impact of his work will likely resonate in the fields of obesity treatment and metabolic health for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…